Frontlight ResearchEarly access
Active, not recruitingNo phase
EFS of the CardioMech MVRS
Key facts
- Who runs it
- CardioMech AS
- Where
- Charlotte, Cincinnati, Cleveland, Evanston, Murray, Nashville, New York, Plano, Rochester, Saint Cloud, Thousand Oaks, and Wichita, United StatesSee the 12 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 35 people, planned
- Started
- 27 Jul 2021
- Expected to end
- Sept 2031
- Type of study
- Interventional
- Treatments tested
- CardioMech MVRS
- Record updated
- 25 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Eighteen (18) years of age or greater
- Moderate to severe (≥3+) or severe (≥4+) mitral valve regurgitation (per American Society of Echocardiography (ASE) guidelines) due to mitral valve prolapse or flail
- Intermediate or high surgical risk for mitral valve repair
Who cannot take part
- History of prior endocarditis
- History of prior repair or replacement of the mitral valve, or annuloplasty
- History of rheumatic heart disease
- Complex mechanism of MR (leaflet perforation, severe leaflet calcifications, commissural extension, commissural prolapse, multiple flail or prolapsing segments, cleft) present on required imaging
- Severely calcified mitral leaflet or has evidence of calcification in the grasping area of the leaflets that would prevent leaflet anchor positioning and deployment
Where in United States
- Atrium Health- Sanger Heart and Vascular InstituteCharlotte, United States
- The Christ HospitalCincinnati, United States
- Cleveland ClinicCleveland, United States
- Northwestern UniversityEvanston, United States
- Intermountain Medical CenterMurray, United States
- Ascension St. Thomas WestNashville, United States
- NYU LangoneNew York, United States
- Baylor Scott & White The Heart HospitalPlano, United States
- Mayo ClinicRochester, United States
- CentraCare Heart & Vascular CenterSaint Cloud, United States
- Cardiovascular Institute of Los Robles Health SystemThousand Oaks, United States
- Ascension St. Francis via ChristiWichita, United States
About the trial
What the trial wants to find out
Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.
The group in the trial
- CardioMech Mitral Valve Repair System (MVRS)Treatment being tested
Treatment: CardioMech MVRS
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Feasibility Study of the CardioMech Mitral Valve Repair System (MVRS)
- Record updated
- 25 September 2026